胰淀素
受体
降钙素
肽
降钙素受体
化学
表型
生物化学
内分泌学
生物
基因
降钙素基因相关肽
神经肽
小岛
胰岛素
作者
Jianjun Cao,M.J. Belousoff,Yi-Lynn Liang,Rachel M. Johnson,Tracy M. Josephs,Madeleine Fletcher,Arthur Christopoulos,Debbie L. Hay,Radostin Danev,Denise Wootten,Patrick M. Sexton
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2022-03-25
卷期号:375 (6587)
被引量:31
标识
DOI:10.1126/science.abm9609
摘要
Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs), AMY1R, AMY2R, and AMY3R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY1R with salmon CT (sCT), AMY2R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI